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Abstract:  The  objective  of  this  paper  is  to  demonstrate  a  simple  Ricardian  model  of 
international  trade  for  health  care  industries of  the  USA and  India.   Our  motivation  is  to 
illustrate that specialization and free trade result in gains from international trade.  We will 
shed  some  light  on  the  economics  of  outbound  as  well  as  inbound  medical  tourism.    By 
adopting the model of comparative advantage to the costs of medical surgeries, we will show 
that trade between our two model countries – India and the USA – is beneficial to both of them.  
By specializing on the type of surgery they are most efficient in producing, it will enhance the 
well being of both nations.  Numerical examples and graphical presentations help to support 
our arguments. 
In addition, we will lift some of the more restrictive assumptions. By including transportation 
costs, barriers of trade as well as a larger variety of surgical services, the central message of 
the beneficial effect of specialization still remains, even though the general picture becomes 
slightly blurred.  There is evidence for support of a more multi-polar international system of 
trade in medical services. 
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123Introduction 
With general tourism on the rise (UNWTO 2009), it is estimated that the volume 
of medical tourists could reach 4 million per annum by 2012 (Deloitte 2008a).  
Medical tourism has become a major force for the growth of service exports world 
wide, while concentrating on a selective number of recipient countries – with India 
and  Thailand  as  major  markets.    At  the  same  time,  medical  tourism  offers  a 
financial valve for the growing burden of health care costs in mature markets like 
the USA. In addition, it provides an alternative for the almost 50 million uninsured 
adults of the USA in receiving affordable and accessible medical services (Senate 
2006, Collins et al. 2008).  The driving force of the outbound medical tourism is 
cost – for surgical services in South Asia these costs are between 10 to 20 percent 
of the corresponding ones in the USA (Unti 2009).  At the same time, hospitals in 
developed  countries  like  Belgium,  Germany  and  the  USA  are  trying  to  attract 
inbound medical tourists by offering special and high quality services (Vequist / 
Valdez 2009).  General trends in global medical tourism are briefly discussed in 
section 1. 
With the help of the traditional Ricardian model of international trade
1, we will 
shed some light on the economics of outbound as well as inbound medical tourism 
in section 2.  By adopting the basic model of comparative advantage to the costs of 
medical surgeries, we will show that trade between our two model countries – 
India and the USA – is beneficial to both of them.  By specializing on the type of 
surgery they are most efficient in producing, it will enhance the well being of both 
nations.  Numerical examples and graphical presentations on dental services and 
medical operations help to support our arguments. In section 3, we will lift some 
of the more restrictive assumptions. By including transportation costs, barriers of 
trade as well as a larger variety of surgical services, the central message of the 
beneficial effect of specialization still remains, even though the general picture 
becomes slightly blurred.  In the final section, we show that there is evidence for 
support of a more multi-polar international system of trade in medical services. 
1  General Trends in Medical Tourism 
Historically, patients of developing countries often journeyed from less developed 
countries to  medical centres  in  more developed countries,  where they received 
services that were not available in their countries of origin - as medical know-how 
and technology was missing.
2 As technology and medical know-how dissolved to 
emerging market countries, a new model of medical tourism – from rich to poor 
1 e.g. in Krugman / Wells 2009 or Mankiw 2009. 
2 See Unti (2009) 18. e.g. wealthy individuals travelled abroad to seek spas, mineral baths, 
innovative therapies in fairer climates in Europe. 
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countries – evolved over the last two decades. Rich country tourists started to 
exploit the possibility to combine tourist aspects with medical ones. Today, one 
finds modern hospital facilities close to major tourist attractions in countries like 
India, South Africa, Thailand and Turkey. Hospitals do look more like first class 
hotels and they actively promote tourist packages  with their  medical services.
3
Therefore,  medical  tourism  increases  in  part  with  the  growth  trend  of  general 
tourism: worldwide international tourist arrivals grew annually by an average of 
4% between 1996 and 2008. Due to the recent recession as well as uncertainties 
brought about by the influenza outbreak, tourism is estimated to take a dip in 2009 
by  -4%  to  -6%.
4  A  sluggish  economic  recovery  might  dampen  the  revival  of 
tourism flows at least in the short term. At the same time the recession could lead 
especially USA insurance companies and employers to re-evaluate how to lower 
ever rising healthcare costs.
5 Not only is the US health-care system by far the most 
expensive in the world – USA health spending runs at 16.2% of GDP, far above 
the OECD average of 9% (2007) , its quality does not compare too well with other 
OECD countries.
6 Medical tourism might be one way to improve services while at 
the  same  time  help  to  dampen  the  rise  in  overall  spending  on  health  care. 
Unfortunately, data on medical tourist flows are poor. Therefore, one has to rely 
on surveys to estimate the flows as well as the economic might of the medical 
tourism industry. In 2006, world wide business in medical tourism grossed about 
$60 bn. It is expected to rise to $100 bn by 2012.
7 India, Malaysia, Singapore and 
Thailand  are  one  of  the  most  attractive  medical  tourist  destinations,  already 
making a significant impact on their economies. In 2005, approximately 500,000 
Americans travelled abroad for medical treatment, by 2007 this number rose to 
750,000 and it is expected to increase to more than 15 million Americans annually 
by 2017.
8 Though, there are others that are much more cautious about the actual 
size  of  the medical  tourism  market:  focusing  on  the  market  segment  of 
international inpatients, three McKinsey analysts estimated a world market for the 
3 E.g. Thailand: Bumrungrad (www.bumrungrad.com); India: Apollo Hospital in Kolkata 
(www.apollogleneagles.in); South Africa: individual doctors (www.surgeon-and-
safari.co.za). 
4 UNWTO (2009) p. 4. 
5 Edelheit (2009) p. 2. From 1960-2006, only in six years – four of them during the Clinton 
boom - did GDP growth actually exceed health care spending growth. In addition, health 
care cost inflation exceeded core inflation in each and every year over the last 50 years 
(McKinsey 2008 p. 37). 
6 e.g. infant mortality or death rate after haemorrhagic strokes (Economist 2008). Also, the 
USA spends $7, 300 per person (in Purchasing-Power Parity), more than twice as much as 
the average of the OECD countries (OECD Health Data 2009 in: Economist 2009 p. 27). 
Even when adjusting for its relative wealth, the USA spends a lot more on health care than 
can be expected (OECD in: Mc Kinsey 2008 p. 36). 
7 McKinsey & Confederation of Indian Industries 2005 in: Herrick (2007) p. 1-2. The $60 
bn (2006) of estimated medical tourism business world wide is less than 8% of total world 
exports in travel (Hussain / Gori 2009 p. 1). 
8 Deloitte Centre for Health Solutions in: Economist (December 22, 2008). 
12520 most important medical-travel destinations of up to 85,000 patients annually for 
2007 only. Besides their focus on patients that are actually staying in a hospital, 
they also subtracted substantial numbers for emergency cases and expatriates. The 
latter  they  did  not  consider  core  medical  tourists.
9  Even  these  conservative 
estimates are still worth looked after, as the growth potential is immense, if certain 
barriers for medical travel - like non-coverage from the country of origin market’s 
payors – would be lifted. 
Let us briefly take a closer look at the major characteristics of international or cross-
border medical tourism. When looking at the broader health care tourism industry, we 
differentiate between wellness tourism and medical tourism.
10 The latter can then be 
further broken down into cosmetic surgery and elective surgery. Our focus will be on 
the non-cosmetic surgeries and medical treatments. In the near past patients from less 
developed countries travelled to major medical centres in industrial countries. There, 
they  looked  for  sophisticated,  often  technologically  advanced  services  that  were 
typically not available in their home countries. These patients were usually wealthy 
individuals. On the reverse you had individuals from rich countries seeking services 
that were either not covered by their health insurance, there were long waiting periods 
for specific treatments in their home country or the services were simply not available 
– often due to legal restrictions like organ transplants or reproductive treatments. The 
majority of those services were of limited medical complexity.
11  
Table 1: 
 Unit Cost for Different Types of Medical Procedures (in USD) 
Type of Procedure  USA Hospital
*  Indian Hospital
*  Thai Hospital
***
Hip Replacement  $50,000  $7,000-$9,000  $12,000-$17,300 
Knee Replacement  $45,000  $6,000-$8,000  $10,700-$13,200 
Heart Bypass  $100,000  $6,000-$9,000  $22,800-$34,300 
PTCA (Angioplasty)  $70,000  $4,000-$7,500  $12,200-$19,800 
Spinal Fusion  $75,000  $5,000-$8,000  $5,500-$7,000 
Breast  Augmention 
(Cosmetic)  $9,000  $3,500-$5,000
**  $2,750 
Face & Neck Lift (Cosmetic)  $11,500  $2,500-$4,000
**  $3,700 
PTCA – Percutaneous Transluminal Coronary Angioplasty 
(*) Median costs. Data retrieved from www.indushealth.com (October 18, 2009). 
(**)  www.medretreat.com (October 18, 2009). 
(***) Bumrungrad Hospital, www.bumrungrad.com (December 16, 2009); range of real costs 
between July 2008 – June 2009; package prices are usually substantially lower. 
9 Based on their survey data and interviews, Ehrbeck et al. (2008 p. 2-3) actually filtered core 
medical travellers down to 35%-45% of all international inpatients. 
10 Caballero-Danell / Mugomba (2006) p. 11. 
11 Unti (2009) p. 18-19. 
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Today, the focus is more on tourists (patients) from developed countries, who travel 
to hospitals in emerging market countries seeking sophisticated - state of the art - 
medical  treatments  at  substantially  lower  cost.  Table  1  presents  typical  types  of 
procedures  and  their  US-costs  compared  to  the  costs  in  attractive  medical  tourist 
destinations. Treatments in India and Thailand refer to high quality, full service and 
internationally accredited hospitals with physicians that were predominantly educated 
at  respectable  universities  in  developed  countries.  These  hospitals  often  seek 
affiliation with a well-known USA or UK teaching hospital to lift standards as well as 
reputation.
12 The potential cost savings per medical treatment is up to 90% of US-
costs.
13 Their cost advantage is based on significantly lower fixed costs, employee 
wages as well as liability insurance premiums.
14 To offer internationally marketable 
and competitive services the hospitals have to be accredited by a third party like the 
Joint  Commission  International  or  comply  to  ISO  9000.
15  Also,  hospitals  offer 
package deals for standard procedures, thereby trying to limit the risk for the patient 
of exploding costs. Since it has become a major industry, several websites of medical 
tourism  agencies  and  even  non-profit  organizations  inform  potential  clients  and 
promote  international  travels  by  linking  the  patients  to  hospitals  or  individual 
physicians.
16  
12 Deloitte (2008a) p. 3. 
13 Examples on individual patients can be found on the websites of medical tourism 
agencies, or e.g. in the Senate Hearing (2006) p. 2-8; Bey (2007) p. 176-177. 
14 Unti (2009) p. 20; see Herrick (2007) p. 9-12 for examples: Indian doctors earn 40% less 
than USA physicians. 
15 The hospitals mention the accreditation on their own websites. But one can also check 
the Joint Commission International for a list of their accredited hospitals 
(www.jointcommissioninternational.org), or the ISO International Standards Organization 
as well as Health Care Tourism certified hospitals (www.healthcaretrip.org). 
16 The following are major websites of medical tourism agencies: MedRetreat in USA 
(www.medretreat.com) including two case studies; Healthcare Tourism International 
(www.healthcaretrip.org) – non-profit organization; Plant Hospitals 
(www.planethospital.com); IndUShealth Inc. (www.indushealth.com) – specializing on 
India and USA patients (also Senate 2006 37-4); Health Tourism (www.health-
tourism.com) and Treatment Abroad in the UK (www.treatmentabroad.net); Hospital Scout 
(www.hospitalscout.com).  
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Figure 1 shows that the world has become a flatter place – we see an influx and 
outflow  of  medical  tourists  from  every  continent  except  for  Africa  and  Oceania. 
Though, the recent focus in medical tourism has been on outbound patient flows – 
from the developed countries to hospitals in the emerging markets in Asia, Europe 
and Latin America. The main driving force is the cost advantage, which is regularly 
mentioned in the recent US health reform debate as being one of the means to keep 
US health spending from getting out of hand. In 2006, there was already a hearing in 
the US Senate discussing the question “Can Medical Tourism Reduce Health Care 
Costs?” The answer sounded like “Yes – but  we just don’t know by  how  much” 
(Senate 2006). At the same time, USA and European hospitals – especially in the UK 
as  well  as  in  Germany  -  are  able  to  attract  foreign  patients  for  high  quality  and 
specialized care.
17 These inbound medical tourists are usually private patients and 
therefore, often provide a financially advantageous source of income – USA hospitals 
17 Gerl et al. (2009) list some of the specialized medical clusters in Europe – either on 
different fields of medicine or focused on special groups of medical tourists (e.g. for Arab 
customers in Bonn, Germany). Also, hospitals in Southern Germany have significant cost 
advantages compared to their Swiss or UK competitors, thereby attracting approximately 
74,000 foreign patients to Germany in 2006 (Juszczak 2007 p. 1, 4, 12) 
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with dedicated international centres generate up to 10 percent of total revenue from 
international patients.
18 So, from a USA or developed country perspective, there are 
inbound  as  well  as  outbound  medical  tourism  flows.  In  the  next  section,  we  will 
present a traditional model on international trade – this time in medical services – to 
shed some light on the economics behind the observed tourism flows. 
2  Medical Services and a Traditional Ricardian 
Model of International Trade 
The concept of comparative advantage and gains from trade are one of the oldest 
ideas in economics (Buchholz 1989).  The principles of comparative advantage was 
introduced  by  David  Ricardo  in  his  1817  book  ‘On  the  Principles  of  Political 
Economy  and  Taxation’,  the  theory  showed  how  nations  benefit  from  free  trade.  
Within the economics literature the improvement in national welfare is known as the 
gains from trade. Ricardo (1817) argued that access to foreign markets is crucial in 
specialization and wealth creation.  Ricardo used a simple model to show how nations 
maximize their material welfare by specializing in goods and services that they have 
the  lowest  relative  costs  of  production.  In  this  section  we  will  demonstrate  some 
empirical evidence for principle of comparative advantage, specialization and wealth 
creation concepts for medical tourism sectors in India and the USA. 
Table 2 summarizes the data on costs of production for dental services in India and 
the USA. The USA has absolute disadvantages in both Dental Implants (DI) and 
Dental Crowns (DC), measured by larger costs of production.  Assuming that the 
dental services are homogenous in quality - can trade bring net national gains to both 
counties? In addition, we assume that there are only two countries, no economies of 
scale, only two kinds of medical services, no transportation costs and no barriers to 
trade. Also, it is assumed that there is perfect knowledge, so that all buyers and sellers 
(patients and hospital management) know where the cheapest goods or the potential 
patients can be found internationally. 
Table 2:  
Unit Costs for Dental Services in India and the USA 
Unit Costs  India (Capacity: 32,000)
*  USA (Capacity: 50,000)
*
Dental Implants  $1,780  $2,780 
Dental Crowns  $400  $1,000 
18 App. 400,000 international patients contribute $5 bn annually to the USA economy 
(Deloitte Center for Health Solutions in: Quesada 2009).  
129(*) Number of hospitals in India (3,200) and the USA (5,000 community hospitals) in 
2007 - assuming ten medical treatments per hospital and day.  Data was retrieved from 
www.medretreat.com (October 18, 2009). 
Based on the number of hospitals in each country, Table 3 summarises maximum 
production capacities in medical treatments per hospital and day for India and the 
USA.  For example, India can produce 18 units of DI if it produces no DC, or 80 
units of DC if it produces no DI.  Similarly, the USA can produce 18 units of DI if 
it produces no DC, or 50 units of DC if it produces no DI. 
Table 3: 
 Maximum Output per Day for India and the USA 
Maximum Output per day  India (Capacity: 32,000)
*  USA (Capacity: 50,000)
*
Dental Implants  32,000 / $1,780 = 18  50,000 / $2,780 = 18 
Dental Crowns  32,000 / $400 = 80  50,000 / $1,000 = 50 
(*) Number of hospitals in India (3,200) and the USA (5,000) in 2007 - assuming ten 
medical  treatments  per  hospital  and  day.    Data  was  retrieved  from 
www.medretreat.com (October 18, 2009). 
Figure 2 illustrates the production possibility frontiers (PPF) for India and the USA.  
It presents the potential production of DC both India and the USA must forgo to 
produce  DI.    The  PPF  shows  the  trade-offs  a  country  faces  when  it  chooses  its 
combination of DI and DC.  It is a straight line because the Ricardian model assumes 
that opportunity costs are constant.  In other words, we state that the trade-off between 
DI and DC does not change.  
Slope of the PPF = ∆DI output / ∆DC output = opportunity cost of DC 
Slope of PPF in (USA) = -0.36  (opportunity cost of DC in the USA) 
Slope of PPF in (India) = -0.225  (opportunity cost of DC in India) 
If the USA does not trade, it gives up 0.36 units of DC for an additional unit of DI.  
This trade-off is called the relative price of DC or the opportunity cost of DC.  The 
term relative price follows from the fact that it is not in monetary units, but rather in 
units of the other good, that is DI.  By the same reasoning, 0.225 units of DC is the 
relative cost (opportunity cost) of one unit of DI in India.  David Ricardo (1817) 
argued that one country has a comparative advantage in producing a good or a service 
if the opportunity cost of producing that good or service is less for the one country 
than for the other country (or countries).  The data of Table 3 indicates that India has a 
comparative advantage in producing DC. At same instance, it means that the USA 
has a comparative advantage in the production of DI.
19  
19 Similar graphical analysis for other commodities like shrimp & computers (Vietnam & 
USA) or meat & potatoes (Farmer & Rancher) can be found in Krugman / Wells (2009) p. 
198-200 or Mankiw (2009) p. 51-53. 
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Number of medical treatments per day and hospital
40 60 70 10 20 30
5
18
(9 DI / 40 DC) (9 DI / 25 DC)
Preferences of 
patients (consumers) in India
Preferences of 
US-Patients
131PPF – Production Possibility Frontier 
The complete absence of trade is called autarky, and in this situation, both India and 
the USA are limited in their consumption to the goods that they produce at home.  
Suppose autarky prevails,  we have assumed both countries divide their respective 
production  capacities  equally  between  DI  and  DC  production.    The  autarky 
production and consumption points for India and the USA are shown in Figure 3.  We 
assume that in autarky, India would choose to produce and consume nine units of DI 
and 40 units of DC.  Table 4 summarises total output of DI and DC for India and the 
USA under autarky.  The total outcome in autarky is summarized in Table 4, where 
the world production and consumption is the sum of India and the USA production 
and consumption, 18 DI and 65 DC, respectively. 
Table 4: 








Dental Implants  16,000 / $1,780 = 9  25,000 / $2,780 = 9  18 
Dental Crowns  16,000 / $400 = 40  25,000 / $1,000 = 25  65 
Table 5 illustrates how both countries gain from specialization and free trade.  As a 
result of comparative advantage and international trade, the USA produces 18 units of 
DI, but no DC, and India produces 80 units of DC, but no DI.  By comparing Table 5 
with Table 4, it is evident that specialization promotes wealth creation measured by 
increase in total world production.  In the absence of specialization and trade (Table 
4),  total  world  production  consists  of  18  units  of  DI  and  65  units  of  DC.    After 
specialization and trade, total world production stands at 18 units of DI and 80 units 
of DC. 
Table 5: 








Dental Implants  0      50,000 / $2,780 = 18  18 
Dental Crowns  32,000 / $400 = 80                 0  80 
Figure  4  summarizes  the  graphical  representation  of  comparative  advantage, 
specialization, free trade and wealth creation concepts for selected dental services (DI 
and DC) for India as well as for the USA. Consumers in both countries are strictly 
better  off  under  free  trade  than  under  autarky.  As  hospitals  in  both  countries 
specialize, a number of Indian medical tourist (nine per day) go to the USA for Dental 
Implants  (inbound  tourism),  at  the  same  time  32  American  patients  seek  Dental 
Crown treatments in Indian hospitals (outbound tourism).  
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CPF – Consumption Possibility Frontier; PPF – Production Possibility Frontier 
In the second part of our basic model section, we focus on two common, but more 
expensive medical services or elective surgeries – Hip Replacement (HIP) and Heart 
Valve  Replacement  (HVR).  American  patients  can  save  up  to  80%-90%  of  the 
respective  US-costs,  when  undertaking  these  procedures  in  an  internationally 
accredited hospital in India. Instead of looking at the hospital capacities of the United 
States  and  India  as  the  determinant  for  the  production  possibilities  of  medical 
services, we assume an arbitrary fixed amount of $750,000/week & hospital to be 
spent in both countries on these two types of procedures. All other assumptions of our 
first model on dental services still hold, e.g. no transportation costs and homogeneous 
services.   
Table 6:  
Typical Costs and Output per Week & Hospital in India and the USA 
Typical  Cost  (per 
surgery) 







Hip Replacement  $7,500  $46,875  100  16 
Heart Valve Replacement  $9,870  $125,000    76    6 
133(*) Typical Indian hospital cost and app. median  USA cost.   
(**)  Total  spending  on  surgeries  is  assumed  to  be  $750,000  per  week  & 
hospital. 
Data was retrieved from www.indushealth.com (October 18, 2009). 
In Table 6, the maximum output levels (per week & hospital) are presented. Due to 
the substantially higher US-costs the output levels of US-hospitals are far below the 
ones in India. This is also reflected in the different production possibility frontiers 
(PPF)  of  the  two  countries  in  Figure  5.  Hospitals  in  India  have  got  absolute 
advantages in the production of hip as well as of Heart Valve Replacements. While 
the  US-hospitals  hold  on  to  a  comparative  advantage  in  the  production  of  Hip 
Replacements as the USA ratio of HIP / HVR is 2.7. This is higher than the one for 
the hospitals in India (HIP / HVR of 1.3). At the same time India has a comparative 
advantage in the production of Heart Valve Replacements.  
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Optimal Production and Consumption under Free Trade
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135CPF – Consumption Possibility Frontier; PPF – Production Possibility Frontier 
Under autarky, we assume that due to the respective preferences of patients in both 
countries, the same amount of financial resources is allocated to each of the two types 
of procedures. Therefore, the American consumers will purchase and the US-hospitals 
will produce three Heart Valve & eight Hip Replacements per week. In India this 
stands at 38 HVR and 50 HIP per week (Figure 5). The moment we allow for medical 
tourism flows between India and the USA, the points of production move towards the 
production of services that each country has a comparative advantage in. Under free 
trade, the US-hospitals will fully specialize in the production of Hip replacements. 
While the hospitals in India shift their production only slightly towards Heart Valve 
Replacement – instead of producing 38 HVR under autarky, they now service 42 
patients per week (Figure 6).  
Why do we not see full specialization in India like we did in our previous example on 
dental  services?  Well,  we  want  to  show  strict  gains  from  international  trade  in 
services. Based on the preferences of patients in both countries, this means that the 
joint  free  trade  output  has  to  exceed  the  total  aggregate  output  for  both  medical 
procedures under autarky. Due to the  vast difference in  the production possibility 
frontiers of the USA and India, full specialization is not feasible for hospitals in India. 
At the same time, this also implicates a substantially smaller gain from trade – the 
fruits of specialization are not fully in reach. Though, free trade is still worth while 
pursuing as joint weekly output per hospital increases by two Hip replacements and 
one Heart Valve Replacement (Table 7). In Figure 6, the consumption possibility 
frontier (CPF) for both countries shifts outward slightly. 
Table 7: 
Gains from Specialization and Free Trade for India and the USA 
India
* USA
* Joint Free Trade Output
(Total Autarky Output)










42  0  42 
(41) 
(*)Total spending on surgeries is assumed to be $750,000 per week & hospital. 
 Data was retrieved from www.indushealth.com (October 18, 2009). 
Our numerical model implicates that three Americans will travel for HVR to India, 
while six Indian patients will fly the opposite direction to be treated in US-hospitals 
for HIP. This outcome results in outbound as well as inbound medical tourism, just 
like  Figure  1  based  on  the  empirical  McKinsey  survey  shows.
20  The  number  of 
20 Ehrbeck et al. (2008) p. 5. 
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medical tourists is moderate – less than 9% of all patients treated in both countries, 
but not insignificant. In the following section, we will apply some extension to this 
basic HIP-HVR model of international trade. 
3  Extensions to the International Trade Model with 
Medical Services 
Up until now, we have applied the traditional Ricardian type trade model on the trade 
of specific medical services (elective surgeries). The flaws of our basic HIP-HVR 
model  are  its  relatively  rigorous  assumptions:  two  country  world,  only  two 
homogeneous services, no barriers of trade, no transportation costs, only one factor of 
production and the way we determined the production capacity of hospitals as well as 
the preferences of patients (consumers) for each country. What effect does the lifting 
of some of those assumptions have on the implications of our model? Due to the 
limited amount of room in this paper, we will concentrate on transportation costs, 
which are quite substantial. For Americans seeking treatment in India, one has to add 
another  $2,000-$6,000  in  travel  costs.
21 Table  8  shows  the  combined  travel  & 
treatment costs for Hip and Heart Valve Replacement. Compared to our basic model, 
the costs of hospitals in India have increased by 44% for HIP and 36% for HVR.
22 In 
addition, for major surgeries, patients might need an assistance or family member to 
accompany them – these costs are still not accounted for.
23  
Table 8: 






























21 Data for travel costs for major types of procedures were retrieved from IndUSHealth 
(www.indushealth.com/pricing October 18, 2009). 
22 As the travel costs for Indians to the USA are relatively minor in relation to the costs for 
the procedures in American hospitals, we did not take them into account. For our numerical 
example, they would not have made a difference. 
23 In addition, risks due to postoperative complications, which might be enhanced by 
immobility and long flight travel, have to be taken into account on an individual patients’ 
base (Unti 2009 p. 24).
137(*)Total spending on surgeries is assumed to be $750,000 per week & hospital. 
 Data was retrieved from www.indushealth.com (October 18, 2009). 
Due to the rise in production costs in India, graphically it’s PPF shifts inward as the 
number  of  medical  services  hospitals  in  India  can  offer  internationally  drop 
substantially  for  both  HIP  (69  vs.  100)  and  HVR  (56  vs.  76).  The  comparative 
advantage  for  each  of  the  country’s  hospitals  remains  the  same.  The  gain  from 
specialization drops to one additional hip replacement under free trade. This is not 
enough of an incentive to induce medical tourism flows. Therefore, if travel costs and 
other additional costs – like special insurance premiums - are substantial, taking them 
into  account  will  reduce  inbound  as  well  as  outbound  tourism,  as  the  gains  from 
specialization vanish. In our numerical example trade in medical services comes to a 
complete halt.  
On the other hand, our assumptions for determining the production capacities in India 
and the USA were most probably too strict. As the USA per capita income ($47,500 
in 2008) by far exceeds the one of India ($2,900),
24 USA consumers are likely to 
spend more on medical services than their Indian counterparts. So, one would have to 
adjust  the  financial  budgets  set  aside  for  the  types  of  procedures  of  interest.  In 
addition, the demand for Hip and Heart Valve Replacement is likely to differ for each 
country. Making these suggested changes in our assumptions will most likely lead to 
the revival of the gains of trade in medical services.
 25 Future research could focus on 
these issues to make our theoretical model ever more realistic. Increasing the variety 
of  medical  services  could  also  lead  to  a  more  multi-polar  world  –  with  various 
countries specializing on the medical treatments they have a comparative advantage 
in. 
4  Implications of International Trade in Medical 
Services 
By  adapting  the  traditional  Ricardian  model  of  international  trade  (in  goods)  to 
different kinds of medical services, we were able to show some of the theoretical 
backgrounds for the rise in world wide medical tourism. The basic numerical and 
graphical presentations supported the drive for inbound as well as outbound patient 
flows – as it is currently reflected in reality (see Figure 1).  In addition, free trade in 
services enhances the economic wealth of open societies or countries. Though, when 
one takes into account substantial transportation (travel) costs, the problem of liability 
insurance as well as the reluctance of US insurance companies to cover these lower 
medical costs of hospitals in foreign countries, the drive towards specialization in 
24 In PPP-U.S.-Dollar (CIA 2009). 
25 Even when relaxing some of the restrictive assumptions, a weaker Ricardian model of 
trade will still show the beneficial sides of free trade (Deardorff 2005 p. 23). 
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medical  services is  slowed down. In addition, potential  savings should amount to 
more than $10,000 or procedures in the USA should be above $6,000 before it is 
financially advantageous to travel abroad for treatment.
26
It should be noted that due to mounting financial pressure on US companies and the 
46  million  uninsured  Americans  (2008),  the  growth  prospect  for  future  outbound
medical tourism does look promising. A large part of USA consumers seem to be 
willing to travel abroad. Their willingness increases with the rise of financial savings 
through  foreign  versus domestic  medical services.
27 Several US health plans  have 
begun to cover surgeries in Thailand and Mexico
28 - banking on reducing health costs 
– thereby further supporting outbound tourism.  
Future research could focus on similar trends and economic conditions within Europe, 
e.g.  looking  at  the  economics  of  medical  tourism  flows  between  Germany  and 
Hungary.  As Budapest and  Hungary  in  general is a  major tourism destination  for 
Germans, Hungarian medical clinics, private as well as state hospitals are already 




[1]  AMA  Medical  Travel  Outside  the  U.S.,  American  Medical  Association, 
Report B (June 2007) 
[2]  Apollo  Gleneagles  at  Kolkata  (www.apollogleneagles.in/package) 
(October 16, 2009) 
[3]  Bey,  T.  Risiken  und  Nebenwirkungen  des  Medizintourismus,  Deutsches 
Ärzteblatt, Jg. 104 Heft 4 (26. Januar 2007) 176-178 
[4]  Buchholz, T. G. (1989) New ideas From Dead Economists, Penguin Group 
[5]  Bumrungrad  International  Bangkok,  Thailand 
(www.bumrungrad.com/realcost/) (December 16, 2009) 
[6]  Caballero-Danell,  S.  /  Mugomba,  C.  Medical  Tourism  and  its 
Entrepreneurial Opportunities – A Conceptual Framework for Entry into 
the Industry, Goteborg University Master Thesis No. 2006:91 
26 www.medretreat.com/procedures/pricing.html (October 18, 2009). The $10,000 
threshold is especially important for USA uninsured (Ehrlich et al. 2007 p. 6-7). 
27 While 3% of all USA consumers have already travelled abroad for medical services, 40% 
of all surveyed would consider an “elective procedure performed in a foreign country if 
they could save 50% or more and be assured that the quality was equal to or better than 
what they can have in the U.S.” (Deloitte 2008b p. 13). 
28 AMA (2007) p.7. 
29 Examples are found at www.dentalcarebudapest.com or Sopron Elizabeth Hospital 
through the British website www.treatmentabroad.net.
139[7]  CIA  World  Factbook,  Central  Intelligence  Agency  (www.cia.gov) 
(December 17, 2009) 
[8]  Deardorff, A.V. How Robust is Comparative Advantage? RSIE Discussion 
Paper  # 537, University of Michigan (May 16, 2005) 
[9]  Deloitte Medical Tourism: The Asian Chapter, Deloitte (2008a) 
[10]  Deloitte  2008  Survey  of  Health  Care  Consumers,  Executive  Summary, 
Deloitte Center for Health Solutions (2008b) 
[11]  Edelheit,  J.  The  Effects  of  the  World  Economic  Recession  on  Medical 
Tourism, Medical Tourism Magazine (April 1, 2009) 
[12]  Economist Heading for the emergency room, Reforming American health 
care (June 25, 2008) (www.economist.com/world/unitedstates/ October 20, 
2009) 
[13]  Economist  Operation  shopping,  Medical  tourism  (December  22,  2008) 
(www.economist.com October 20, 2009) 
[14]  Economist  After  the  gold  rush,  Briefing  National  Health  Service 
(December 12, 2009) p. 27-29 
[15]  Ehrbeck, T. / Guevara, C. / Mango, P.D. Mapping the Market for Medical 
Travel, Health Care, The McKinsey Quarterly (May 2008) 
[16]  Gerl, R. / Boscher, L. / Mainil, T. / Kunhardt, H. European Competence 
Centres  for  Health  &  Medical  Tourism,  Medical  Tourism  Magazine 
(October 1, 2009) 
[17]  Herrick,  D.M.  Medical  Tourism:  Global  Competition  in  Health  Care, 
NCPA Policy Report No. 304 (November 2007) National Center for Policy 
Analysis 
[18]  IndUShealth (www.indushealth.com) (October 18, 2009)  
[19]  JCI  (2009)  Joint  Commission  International 
(www.jointcommissioninternational.org  Accredited  Organizations) 
(October 20, 2009) 
[20]  Juszczak,  J.  Internationale  Patienten  in  deutschen  Kliniken:  Ansätze  zur 
Vermarktung von Gesundheitsdienstleistungen im Ausland, Schriftenreihe 
des  Fachbereichs  Wirtschaftswissenschaften  Sankt  Augustin,  Bd.  8, 
Fachhochschule Bonn-Rhein-Sieg (Februar 2007) 
[21]  Hussain, M. / Gori, S. EU residents spent €94.2bn outside the EU for travel 
purposes in 2007, eurostat Statistics in focus 23/2009 
[22]  Krugman, P. / Wells, R. Economics, 2nd edition Worth Publishers (2009) 
[23]  Mankiw, N.G. Principles of Macroeconomics, 5th edition South-Western 
Cengage Learning (2009) 
140
 
M. Piazolo, N. A. Zanca
!"# $%&'&()%* &+ ,#-)%./ !&01)*( 2 3.*# 450-6 +&1 5"# 742 .'- 8'-). MEB 2010 – 8
th International Conference on Management, Enterprise and Benchmarking
June 4–5, 2010 • Budapest, Hungary
[24]  McKinsey Accounting for the cost of US health care: A new look at why 
Americans spend more, McKinsey Global Institute (November 2008) 
[25]  MedRetreat  www.medretreat.com/procedures/pricing.html  (October  18, 
2009) 
[26]  Planet Hospital (www.planethospital.com) (October 18, 2009) 
[27]  Quesada, J. Medical Tourism - An Economic Boost to the United States, 
Medical Tourism Magazine (online August 4, 2009) 
[28]  Ricardo, D. On the Principles of Political Economy and Taxation, London: 
John Murray, 1817. 
[29]  Senate  (2006)  The  Globalization  of  Health  Care:  Can  Medical  Tourism 
Reduce  Health  Care  Costs?  Hearing  before  the  Special  Committee  on 
Aging United States Senate, Serial No. 109-26 (June 27, 2006) 
[30]  Vequist, D. / Valdez, E. Economic Report: Inbound Medical Tourism in the 
United States, Medical Tourism Magazine (online August 4, 2009) 
[31]  UNWTO Tourism Highlights 2009 Edition, World Tourism Organization 
(September 27, 2009) 
[32]  Unti, J.A. (2009) Medical and surgical tourism: The new world of health 
care globalization and what it means for the practicing surgeon, Bulletin of 
the American College of Surgeons Vol. 94 No. 4 (April) 18-25 
141